Last reviewed · How we verify
NCT05897801: CRONUS
Distinguishing Bacterial and Viral Infections by MeMed BV® Test to Limit Gut Colonization by MDRO
trial testing MeMed BV® in Viral Infection in 230 participants. Completed in 31 January 2024.
18 December 2023
Quick facts
| Lead sponsor | Hellenic Institute for the Study of Sepsis |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 230 |
| Start date | 29 May 2023 |
| Primary completion | 18 December 2023 |
| Estimated completion | 31 January 2024 |
| Sites | 3 locations across Greece |
Drugs / interventions tested
- MeMed BV®
Conditions studied
- Viral Infection — all drugs for Viral Infection →
- Bacterial Infections — all drugs for Bacterial Infections →
- Multi-antibiotic Resistance — all drugs for Multi-antibiotic Resistance →
- Respiratory Tract Infections — all drugs for Respiratory Tract Infections →
Sponsor
Hellenic Institute for the Study of Sepsis
Who can join
18 and older, any sex, with Viral Infection or Bacterial Infections. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The fast increase of Multidrug-resistant microorganisms (MDRO) due to the high amount of antimicrobials being poorly used may be limited by better regulating antimicrobial usage globally. The goal of this observational study is the performance of the MeMed BV® test in the MeMed Key® device at the emergency department to a) support the differential diagnosis between bacterial and viral infections of the respiratory tract and b) provide evidence of how the use of this test may limit gut colonization by MDRO.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05897801
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of MeMed BV®
Trials testing the same drug.
- NCT05439551 — Evaluating the Analytical Equivalency of Serum and Whole Blood Samples Run on the MeMed Key® Platform (Perseverance Stud · completed
- NCT04709978 — Community Acquired Pneumonia in Older Adults · completed
Other recruiting trials for Viral Infection
Currently open trials in the same condition.
- NCT06931002 — A Rhinovirus Challenge Study to Investigate Exacerbations and Immune Responses in Bronchiectasis · NA · recruiting
- NCT06271655 — Rapid Diagnosis of Viral Acute Respiratory Infection to Decrease Unnecessary Antibiotic Utilization in the Emergency Dep · NA · active not recruiting
- NCT05671159 — COMPArative Study of the Consequence on innaTe Immune Response du to Bacterial or Viral Infection in Patients Admitted t · NA · recruiting
- NCT05246098 — REVIVe: Frailty, Rehabilitation, and Outcomes in Critically Ill Adult and Pediatric Survivors of COVID-19 or ARI · recruiting
- NCT04691622 — Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts · Phase 1 · recruiting
Other Hellenic Institute for the Study of Sepsis trials
Trials by the same sponsor.
- NCT06608849 — The Incidence of Pulmonary, Cardiovascular and Renal System Non-communicable Complications Associated With the Post-acut · recruiting
- NCT06601998 — Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Covid-19. · recruiting
- NCT07073456 — Viscoelastic Coagulation for Early Sepsis Detection · recruiting
- NCT06294600 — Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT) · Phase 3 · recruiting
- NCT06141395 — NGS-Based Assay of Blood Samples of Sepsis Patients for Rapid Bacterial Identification · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05897801 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hellenic Institute for the Study of Sepsis
- Last refreshed: 6 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05897801.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing